On Navigating a 14-Month Biotech Seed Round & Making Whole Milk from Mammary Cells- Opalia: Jennifer

On Navigating a 14-Month Biotech Seed Round & Making Whole Milk from Mammary Cells- Opalia: Jennifer

June 10, 2026 · 31 min

About this episode

Jennifer Côté discusses her experience navigating a biotech seed round and the innovative process of creating animal-free dairy.

Episode 103: Opalia: Jennifer Côté on Navigating a 14-Month Biotech Seed Round and Making Whole Milk from Mammary Cells In this episode, I sit down with Jennifer Côté , CEO and Co-Founder of Opalia , a Montreal-based biotechnology company pioneering animal-free dairy by producing real whole milk from bovine mammary cells. Jennifer shares a transparent, reality-check account of what it takes to close a $3.2M CAD Seed round in the challenging 2026 funding climate. She breaks down the technical differentiation that separates cellular dairy from the struggling cultivated meat sector, explains how to leverage non-dilutive government grants, and details the grueling process of filtering a pipeline of 400 investors down to a committed, high-quality cap table. 🎧 Listen to the full episode to hear Jennifer’s take on building a "Type A" hyper-transparent data room, how she fields macro environmental objections, and why real transparency beats over-inflated hype when partnering with sector-specific venture capital. Key Facts: Opalia Jennifer Côté: https://www.linkedin.com/in/jennifer-cote/ Website: opaliafoods.com Headquarters: Montreal, Canada. Goal: To eliminate the intensive global…

People in this episode

Host: Alex Shandrovsky

Guest: Jennifer Côté

Topics covered

Keywords

Mentioned in this episode

Organizations: Opalia

Places: Montreal, Canada

More episodes of Investment Climate

Explore listener stats, chart rankings, contacts and more on the Investment Climate podcast page.